Neuropsicofarmacología molecular
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaInstituto de Investigación Sanitaria Aragón-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2018
-
Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
International Journal of Neuropsychopharmacology, Vol. 21, Núm. 5, pp. 410-422
2016
-
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
Journal of Psychiatric Research, Vol. 75, pp. 14-21